Session Description:

EPA 2021 Janssen-sponsored satellite symposium online summary:

This symposium will provide delegates with expert perspectives on optimum schizophrenia management under the challenging conditions of the COVID-19 pandemic. The session will examine considerations for maintenance treatment and long-term care, optimisation of the multidisciplinary team approach to schizophrenia care, and balancing caring for both the mental and physical health of patients with schizophrenia. Topics will include the use of telemedicine in schizophrenia management, recommendations for delivering optimum treatment continuity under social distancing conditions, and the pros and cons of monitoring schizophrenia treatment adherence and outcomes in person as well as through alternative monitoring approaches. In addition, the changes in exposure to antipsychotic medication in patients with schizophrenia during the pandemic will be discussed.

This will be a highly engaging symposium, offering a multitude of fresh perspectives on the current hot topics in schizophrenia management and providing the virtual audience with the opportunity to further benefit from additional insights delivered during our expert faculty discussion.

Educational financial support is provided by Janssen.